Pediatric And Rare Disease Drug Development Legislation Clears US House Committee

 
• By Sue Sutter

As amended, the Give Kids A Chance Act would renew the rare pediatric disease voucher program for five years and give the FDA new authority to bring enforcement action when pediatric studies are overdue. However, it would not remove the exemption from pediatric study requirements for non-cancer orphan drugs, which Democrats had sought. 

Gift packaging
A bipartisan package of measures targeting rare and pediatric disease drug development cleared a House committee. • Source: Shutterstock

More from Legislation

More from Pink Sheet